Positive HSV-2 vaccine Phase I results + aggressive CardioCel updates into EU and US and news of the shed opening should see a valuation of around 45-50c or say $600 - $700 million. According to my reckoning anyway.
I have no idea where it might drift in the short term though as you can never underestimate how impatient most people are these days so if we don't get some news on either of these fronts soon maybe investors will sell to go off and look for a bit more action……
Another product for adapt coming soon, page-26
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.00 |
Change
-0.150(1.48%) |
Mkt cap ! $211.3M | |||
| Open | High | Low | Value | Volume |
| $10.26 | $10.35 | $9.80 | $295.8K | 29.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22 | $9.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.00 | 2758 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |